In November 2023, the Jiangsu Productivity Promotion Center released the evaluation results of Jiangsu unicorn enterprises, Jiangsu potential unicorn enterprises and Southern Jiangsu Self-Innovation Zone Gazelle Enterprises in 2023. Boyi Bio was successfully selected as a potential unicorn enterprise in Jiangsu in 2023, and its holding subsidiary Tiandirenhe was successfully selected as a gazelle enterprise in Southern Jiangsu Self-Innovation Zone in 2023.

Boyi Bio Group was founded in 2022. Currently, Boyi Group owns Tiandi Renhe, Boyi Bio, Hongmeng Bio, ACE and other brands. The company's main business layout is in the three major business sectors of biological macromolecule purification, core raw materials for in vitro diagnostic reagents and life research reagents. The company takes innovation as its mission and always focuses on key core technology research. Last year, the R&D expenditure was nearly 10 million yuan, and the investment intensity of scientific and technological activities reached 13%. So far, the company has obtained 6 authorized invention patents and 62 utility model patents.

Boyi Bio will be committed to developing upstream and downstream tool products for life sciences, realizing product value for customers with professional technology and high-quality services, and playing an innovative leading role in the high-quality development of the synthetic biology track!

Boyi Bio Group was founded in 2022. Currently, Boyi Group owns Tiandi Renhe, Boyi Bio, ACE and other brands. The company's main business layout is in the three major business sectors of biological macromolecule purification, core raw materials for in vitro diagnostic reagents and life research reagents. The company takes innovation as its mission and always focuses on key core technology research. Last year, the R&D expenditure was nearly 10 million yuan, and the investment intensity of scientific and technological activities reached 13%. So far, the company has obtained 6 authorized invention patents and 62 utility model patents.

Boyi Bio will be committed to developing upstream and downstream tool products for life sciences, realizing product value for customers with professional technology and high-quality services, and playing an innovative leading role in the high-quality development of the synthetic biology track!

POTENTIAL UNICORN ENTERPRISES IN JIANGSU

The three core characteristics of potential unicorn enterprises in Jiangsu are high technology, high growth and high value. At the same time, they need to meet the following three basic conditions to be selected.

1. Hard technology enterprises registered in Jiangsu Province, with independent legal person status and no bad credit record;

2. Received investment and not yet listed;

3. Established within 5 years (established in 2018 and later) and valued at not less than US$50 million (or RMB 300 million), or established for 5 to 9 years (established in 2013 to 2017) and valued at US$1 to 1 billion.

GAZELLE ENTERPRISES IN THE SELF-CREATED ZONE OF SOUTHERN JIANGSU

Gazelle enterprises refer to enterprises that have successfully crossed the start-up period and entered the high-speed growth period with a leapfrog development trend. They have the characteristics of fast growth, strong innovation ability, new professional fields and great development potential.